In this issue:
- Serum free thiols in IBD
- Perspiration-based monitoring of CRP, IL-6, and calprotectin
- Prognostic value of modified Rutgeerts score post ileocecal resection in CD
- Intestinal barrier biomarkers in IBD
- Tofacitinib in acute severe UC
- TDM for biologic and small molecule therapies for IBD
- Vedolizumab and ustekinumab levels in pregnancy
- Thiopurine metabolite shunting in late pregnancy and risk of ICP
- Risk factors for malignancy and serious infection in IBD
- Combination allopurinol thiopurine vs standard thiopurine
- Science blog: The ileum in CD
Please login below to download this issue (PDF)